Similarly, a more potent analog of CA9 inhibitor, SLC-0111, FC12-531A exhibited IC50s ~15-fold lower than SLC-0111 in this 3D tumor spheroid model (Fig. 3E,F and Table 1), demonstrating improved potency in its tumor growth-inhibitory effects over SLC-0111. This evidence concerns the gene CA9 and neoplasm.